Heat Biologics Announces Initiation of the Lead Clinical Trial Site for PTX-35

Jun 18, 2020

Heat Biologics Announces FDA Clearance of Investigational New Drug (IND) Application for PTX-35

Jun 8, 2020

Heat Biologics Provides Update on COVID-19 Vaccine Efforts

Jun 4, 2020

Heat Biologics Presents Positive Survival Benefit for HS-110 in Combination with Nivolumab in Phase 2 Lung Cancer Trial at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

May 29, 2020

Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine

May 27, 2020

Heat Biologics Provides First Quarter 2020 Business Update

May 15, 2020

Positive Survival Data from Phase 2 Lung Cancer Trial Accepted for Presentation at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

May 14, 2020

Heat Biologics Provides Clinical Update; Reports Continued Progress Advancing HS-110

May 11, 2020

Heat Biologics Reports Progress on COVID-19 Efforts and Timeline of Anticipated Q2 2020 Milestones

Apr 29, 2020

Heat Biologics Announces Formation of COVID-19 Advisory Board

Apr 1, 2020